Thu, 22 Nov 2007 03:40:27 +0000

C V Therapeutics' angina drug filings accepted (PharmaBiz)

by Angina (Angina) @ Thu, 22 Nov 2007 03:40:27 +0000
Biopharmaceutical company, CV Therapeutics, Inc. announced that the US Food and Drug Administration (FDA) has accepted its supplemental new drug application (sNDA) as well as its new drug application (NDA) for chronic angina drug Ranexa.
Healthy Living Centre